News
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
StockStory.org on MSN18h
Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics SegmentAs the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Pharma giant Gilead Sciences agreed to pay hundreds of millions of dollars to state health insurance programs after admitting ...
17h
Gulf Business on MSNGilead’s Vítor Papão on key partnerships and the role of tech in public healthGilead's Papao shares insights on the evolving role of public-private collaboration in healthcare, and how emerging tech is ...
Merck & Co., Inc. outshines Gilead Sciences, Inc. with stronger dividend growth, valuation metrics & PEGY ratio. Click for our updates on GILD and MRK.
The scheme involved incentives to healthcare providers, leading to false claims to government programs like Medicaid.
CHICAGO Attorney General Kwame Raoul, as part of a bipartisan coalition of 49 attorneys general, announced a $202 million multistate settlement agreement ...
LOS ANGELES, July 16, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that ...
Gilead Sciences will pay more than $200 million after admitting to a multi-year illegal kickback scheme that pushed its HIV drugs through lavish perks for prescribers. New York Attorney General ...
NY Attorney General Letitia James wins a $202 million settlement against Gilead Sciences for illegal kickbacks.
The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results